Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017 (2017), Article ID 7698452, 2 pages
https://doi.org/10.1155/2017/7698452
Letter to the Editor

Comment on “Application of PK/PD Modeling in Veterinary Field: Dose Optimization and Drug Resistance Prediction”

Department of Diagnostics and Public Health, Pharmacology Section, University of Verona, Verona, Italy

Correspondence should be addressed to Anna Benini

Received 17 May 2017; Accepted 3 July 2017; Published 18 July 2017

Academic Editor: Abdelwahab Omri

Copyright © 2017 Anna Benini and Guido Francesco Fumagalli. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. Ahmad, L. Huang, H. Hao, P. Sanders, and Z. Yuan, “Application of PK/PD modeling in veterinary field: dose optimization and drug resistance prediction,” BioMed Research International, vol. 2016, Article ID 5465678, 12 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. M. N. Martinez, M. G. Papich, and G. L. Drusano, “Dosing regimen matters: the importance of early intervention and rapid attainment of the pharmacokinetic/pharmacodynamic target,” Antimicrobial Agents and Chemotherapy, vol. 56, no. 6, pp. 2795–2805, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Martinez, J. Blondeau, C. E. Cerniglia et al., “Workshop report: the 2012 antimicrobial agents in veterinary medicine: exploring the consequences of antimicrobial drug use: a 3-D approach,” Journal of Veterinary Pharmacology and Therapeutics, vol. 37, no. 1, pp. 1–16, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. P. G. Ambrose, S. M. Bhavnani, C. M. Rubino et al., “Pharmacokinetics-pharmacodynamics of antimicrobial therapy: it's not just for mice anymore,” Clinical Infectious Diseases, vol. 44, no. 1, pp. 79–86, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. C. Giuliano, K. K. Haase, and R. Hall, “Use of vancomycin pharmacokinetic-pharmacodynamic properties in the treatment of MRSA infections,” Expert Review of Anti-Infective Therapy, vol. 8, no. 1, pp. 95–106, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Barbour, F. Scaglione, and H. Derendorf, “Class-dependent relevance of tissue distribution in the interpretation of anti-infective pharmacokinetic/pharmacodynamic indices,” International Journal of Antimicrobial Agents, vol. 35, no. 5, pp. 431–438, 2010. View at Publisher · View at Google Scholar · View at Scopus